Anti-CKLF6/ CM™6/ CKLFSF6 monoclonal antibody

Anti-CKLF6/ CM™6/ CKLFSF6 antibody for FACS & in-vivo assay

Target products collectionGo to CM™6/CM™6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0308-Ab-1/ GM-Tg-hg-MP0308-Ab-2Anti-Human CM™6 monoclonal antibodyHuman
GM-Tg-rg-MP0308-Ab-1/ GM-Tg-rg-MP0308-Ab-2Anti-Rat CM™6 monoclonal antibodyRat
GM-Tg-mg-MP0308-Ab-1/ GM-Tg-mg-MP0308-Ab-2Anti-Mouse CM™6 monoclonal antibodyMouse
GM-Tg-cynog-MP0308-Ab-1/ GM-Tg-cynog-MP0308-Ab-2Anti-Cynomolgus/ Rhesus macaque CM™6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0308-Ab-1/ GM-Tg-felg-MP0308-Ab-2Anti-Feline CM™6 monoclonal antibodyFeline
GM-Tg-cang-MP0308-Ab-1/ GM-Tg-cang-MP0308-Ab-2Anti-Canine CM™6 monoclonal antibodyCanine
GM-Tg-bovg-MP0308-Ab-1/ GM-Tg-bovg-MP0308-Ab-2Anti-Bovine CM™6 monoclonal antibodyBovine
GM-Tg-equg-MP0308-Ab-1/ GM-Tg-equg-MP0308-Ab-2Anti-Equine CM™6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0308-Ab-1/ GM-Tg-hg-MP0308-Ab-2; GM-Tg-rg-MP0308-Ab-1/ GM-Tg-rg-MP0308-Ab-2;
GM-Tg-mg-MP0308-Ab-1/ GM-Tg-mg-MP0308-Ab-2; GM-Tg-cynog-MP0308-Ab-1/ GM-Tg-cynog-MP0308-Ab-2;
GM-Tg-felg-MP0308-Ab-1/ GM-Tg-felg-MP0308-Ab-2; GM-Tg-cang-MP0308-Ab-1/ GM-Tg-cang-MP0308-Ab-2;
GM-Tg-bovg-MP0308-Ab-1/ GM-Tg-bovg-MP0308-Ab-2; GM-Tg-equg-MP0308-Ab-1/ GM-Tg-equg-MP0308-Ab-2
Products NameAnti-CM™6 monoclonal antibody
Formatmab
Target NameCM™6
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CM™6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CKLF6/ CM™6/ CKLFSF6 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP000070human CM™6 Lentivirus particle
    ORF Viral VectorpGMLP000070human CM™6 Lentivirus plasmid


    Target information

    Target IDGM-MP0308
    Target NameCM™6
    Gene ID54918,67213,316035,704441,609718,101081491,508881,100630157
    Gene Symbol and Synonyms2810051A14Rik,CKLFSF6,CM™6,Da2-17,LRRGT00102,PRO2219
    Uniprot AccessionQ9NX76
    Uniprot Entry NameCKLF6_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000091317
    Target ClassificationN/A

    The target: CM™6, gene name: CM™6, also named as CKLFSF6, PRO2219. This gene belongs to the chemokine-like factor gene superfamily, a novel family that is similar to the chemokine and transmembrane 4 superfamilies. This gene is one of several chemokine-like factor genes located in a cluster on chromosome 3. This gene is widely expressed in many tissues, but the exact function of the encoded protein is unknown. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.